Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -14.919% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a.) CCN(Cc1ccccc1)C(=O)CCNS(=O)(=O)c1cc(Br)cnc1N
b.) CNc1snc(C)c1C(=O)OCC(=O)c1cc(F)ccc1OC
c.) CCC(=O)Nc1nc2cc(OC)ccc2s1
d.) CCOC(=O)C1CCN(C(=O)c2sc3ncnc(N4CCC(C)CC4)c3c2C)CC1
e.) CC(C)NCC(O)COc1ccc(Br)cc1.Cl
Answer: a. CCN(Cc1ccccc1)C(=O)CCNS(=O)(=O)c1cc(Br)cnc1N
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN(Cc1ccccc1)C(=O)CCNS(=O)(=O)c1cc(Br)cnc1N
CCN(Cc1ccccc1)C(=O)CCNS(=O)(=O)c1cc(Br)cnc1N
3-[(2-amino-5-bromopyridin-3-yl)sulfonylamino]-N-benzyl-N-ethylpropanamide